Acceleron Pharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Acceleron Pharma

Access the complete profile.

Acceleron Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5411 Legal Services
Address	126 East Lincoln Avenue P.o. Box 2000 Rahway, NJ 07065

Note: Revenues for privately held companies are statistical evaluations.


Acceleron Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Acceleron Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Acceleron Pharma is classified as operating in the Legal Services industry, NAICS Code 5411.

Acceleron Pharma Annual Revenue and Growth Rate

Acceleron Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Acceleron Pharma's revenues are gauged from an analysis of company filings.

Acceleron Pharma's Income Statement (based on Industry Averages)

Acceleron Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Acceleron Pharma is developing and marketing. Acceleron Pharma doesn't have any recent trademark applications, indicating Acceleron Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ARYVESS Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pulmonary hypertension	06/10/2021
AROVYSS Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pulmonary hypertension	06/10/2021
ARYVOSS Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pulmonary hypertension	06/10/2021

See all trademarks and details in the Full Report.

Market Share of Acceleron Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Acceleron Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Acceleron Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
LOWENSTEIN SANDLER	Roseland, NJ	100
DAY PITNEY	Parsippany, NJ	90
CHIESA SHAHINIAN & GIANTOMASI PC	Roseland, NJ	59
CONNELL FOLEY	Roseland, NJ	39
WILENTZ GOLDMAN & SPITZER PA	Woodbridge, NJ	34
PRESSLER FELT & WARSHAW	Parsippany, NJ	28

Other Companies at 126 East Lincoln Avenue, Rahway NJ

Company	Headquarters	Revenue ($ MM)
MERCK SHARP & DOHME	Rahway, NJ	100
MERCK	Rahway, NJ	95
PANDION THERAPEUTICS	Rahway, NJ	0

Future Competition: Acceleron Pharma's Fastest Growing Competitors

These companies are in the same general field as Acceleron Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)